Sentence: Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer : a study of the Princess Margaret Hospital Phase II Consortium .
Drug combination annotation:
[{'class': 'POS', 'spans': ['Sorafenib', 'gemcitabine'], 'is_context_needed': True}]